日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Multitarget Compound ZLY032 Achieves Treatment of Chronic Wounds.

多靶点化合物 ZLY032 可治疗慢性伤口

Gong Manyu, Du Zhiyuan, Gong Tiantian, Wang Yu, Yin Chenchen, Sun Bosi, Liu Zijia, Chen Lianru, Liao Zibin, Wang Wenxin, Zhao Tianjiao, Wang Yifei, Dong Ying, Wang Kexin, Ma Mengru, Li Weijun, Li Jiacheng, Li Haodong, Lin Congcong, Zhang Ying, Liu Yu, Liu Xin, Ban Tao, Bao Hongxia, Zhang Ying, Zhang Yang, Li Zheng, Jiao Lei

Discovery of novel FABP1 inhibitors for the treatment of metabolic dysfunction-associated steatohepatitis and hepatic fibrosis

发现新型FABP1抑制剂用于治疗代谢功能障碍相关性脂肪性肝炎和肝纤维化

Zhou, Zongtao; Luo, Zhonghui; Lv, Xudong; Chen, Lianru; Qin, Zhihong; Ma, Qi; Li, Zheng; Kong, Deyang

iRGD synergizes with PD-1 knockout immunotherapy by enhancing lymphocyte infiltration in gastric cancer

iRGD 与 PD-1 敲除免疫疗法协同作用,增强胃癌淋巴细胞浸润

Naiqing Ding, Zhengyun Zou, Huizi Sha, Shu Su, Hanqing Qian, Fanyan Meng, Fangjun Chen, Shiyao Du, Shujuan Zhou, Hong Chen, Lianru Zhang, Ju Yang, Jia Wei, Baorui Liu